- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04059848
Transcranial Direct Current Stimulation Combined Neuromuscular Electrical Stimulation on Motor Recovery in Stroke
August 15, 2019 updated by: Kaohsiung Medical University Chung-Ho Memorial Hospital
The purpose of this study was to investigate the effects of the combination treatment strategy.
A randomized, double-blinded and sham-stimulation study was conducted.
Twenty-six participants with chronic stroke (onset > 6 months) were assigned into one of three groups (tDCS combined with NMES, tDCS combined with sham NMES, or sham tDCS combined with sham NMES) by block randomization.
In addition to conventional rehabilitation, all subjects received an additional protocol with a total of 15 sessions for 3 weeks (5 times per week, 30 minutes daily).
The UE subscale of Fugl-Meyer assessment (UE-FMA) and Action Research Arm Test (ARAT) as primary outcome measures were assessed at beginning of the intervention, after 3-week of treatment, and one-month follow-up.
No significant differences in the primary outcome measures at post-treatment and one-month follow-up were found among the tDCS combined with NMES group (n=9), tDCS combined with sham NMES group (n=9), and the sham tDCS combined with sham NMES group (n=8).
However, significant changes in UE-FMA (from baseline to post-treatment, p= .02)
and ARAT (from baseline to post-treatment, p= .04)
score were found for the tDCS combined with NMES group.
This preliminary study reveals that the tDCS combined with NMES appears to be beneficial to UE motor recovery after stroke but is not superior to the tDCS alone.
Study Overview
Status
Completed
Conditions
Detailed Description
Background and objectives: Previous studies have shown that transcranial direct current stimulation (tDCS) and Neuromuscular electrical stimulation (NMES) could be effective for promoting motor recovery of stroke patients.
However, the effects of tDCS combined with NMES on upper extremity (UE) motor recovery in patients with stroke have not been investigated.
The purpose of this study was to investigate the effects of the combination treatment strategy.
Methods: A randomized, double-blinded and sham-stimulation study was conducted.
Twenty-six participants with chronic stroke (onset > 6 months) were assigned into one of three groups (tDCS combined with NMES, tDCS combined with sham NMES, or sham tDCS combined with sham NMES) by block randomization.
In addition to conventional rehabilitation, all subjects received an additional protocol with a total of 15 sessions for 3 weeks (5 times per week, 30 minutes daily).
The UE subscale of Fugl-Meyer assessment (UE-FMA) and Action Research Arm Test (ARAT) as primary outcome measures were assessed at beginning of the intervention, after 3-week of treatment, and one-month follow-up.
Results: Most of the participants had mild to moderate disability in activity of daily living.
No significant differences in the primary outcome measures at post-treatment and one-month follow-up were found among the tDCS combined with NMES group (n=9), tDCS combined with sham NMES group (n=9), and the sham tDCS combined with sham NMES group (n=8).
However, significant changes in UE-FMA (from baseline to post-treatment, p= .02)
and ARAT (from baseline to post-treatment, p= .04)
score were found for the tDCS combined with NMES group.
Conclusion: This preliminary study reveals that the tDCS combined with NMES appears to be beneficial to UE motor recovery after stroke but is not superior to the tDCS alone.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- First onset
- Ischemic stroke
- Stroke onset > 6 months
- Brunnstrom recovery stage: ≧3
- Modified Ashworth Scale Elbow flexor : ≦3
Exclusion Criteria:
- Severe language or cognitive impairment
- Orthopaedic or neurological problems
- Pregnancy
- Contraindications for tDCS or NMES
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: tDCS combined with NMES
In addition to conventional rehabilitation, all subjects received an additional tDCS combined with NMES protocol with a total of 15 sessions for 3 weeks (5 times per week, 30 minutes daily).
|
|
Active Comparator: tDCS combined with sham NMES
In addition to conventional rehabilitation, all subjects received an additional tDCS combined with sham NMES protocol with a total of 15 sessions for 3 weeks (5 times per week, 30 minutes daily).
|
|
Sham Comparator: sham tDCS combined with sham NMES
In addition to conventional rehabilitation, all subjects received an additional sham tDCS combined with sham NMES protocol with a total of 15 sessions for 3 weeks (5 times per week, 30 minutes daily).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
upper extremity subscale of Fugl-Meyer assessment
Time Frame: at beginning of the intervention, after 3-week of treatment, and one-month follow-up
|
The Fugl-Meyer assessment consists of the 33-item upper-extremity (UE-FM) and 17-item lower-extremity subscales.(Fugl-Meyer
et al., 1975) The items of the FM are mainly scored on a 3-point scale, from 0 to 2. The total score of the UE-FM ranges from 0 to 66.
|
at beginning of the intervention, after 3-week of treatment, and one-month follow-up
|
Action Research Arm Test
Time Frame: at beginning of the intervention, after 3-week of treatment, and one-month follow-up
|
The ARAT(Lyle, 1981) has 19 items in four categories: grasp, grip, pinch, and gross movement.
Each item is graded on a 4-point scale, from 0 to 3. The total score has a range of 0 to 57.
|
at beginning of the intervention, after 3-week of treatment, and one-month follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 13, 2017
Primary Completion (Actual)
July 30, 2019
Study Completion (Actual)
July 31, 2019
Study Registration Dates
First Submitted
August 14, 2019
First Submitted That Met QC Criteria
August 15, 2019
First Posted (Actual)
August 16, 2019
Study Record Updates
Last Update Posted (Actual)
August 16, 2019
Last Update Submitted That Met QC Criteria
August 15, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KMUHIRB F(I)-20150053
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Stroke
-
The University of Texas Health Science Center,...Recruiting
-
National Yang Ming UniversityCompleted
-
IRCCS San Raffaele RomaIRCCS Sacro Cuore Don Calabria di Negrar; Ospedale Riabilitativo di Alta Specializzazione... and other collaboratorsCompletedCardiovascular Diseases | Vascular Diseases | Cerebrovascular Disorders | Brain Diseases | Central Nervous System Diseases | Acute Stroke | Chronic Stroke | Severe Stroke | Mild StrokeItaly
-
University of Illinois at ChicagoNot yet recruiting
-
VA Office of Research and DevelopmentRecruitingChronic StrokeUnited States
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Michael Smith Foundation for...RecruitingStroke | Stroke, Ischemic | Stroke Hemorrhagic | Chronic StrokeCanada
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Chronic Stroke | Subacute StrokeThailand
-
University of WashingtonRecruitingStroke, Ischemic | Chronic StrokeUnited States
-
Ever Neuro Pharma GmbHVASCage GmbHTerminatedChronic Stroke | Subacute StrokeAustria
-
IRCCS San Raffaele RomaAzienda Ospedaliero, Universitaria Pisana; I.R.C.C.S. Fondazione Santa Lucia; Fondazione Don Carlo Gnocchi Onlus and other collaboratorsCompletedStroke | Acute Stroke | Chronic StrokeItaly
Clinical Trials on tDCS(Intelect Mobile Stimulation and Combination, DJO, France)
-
Federal University of Health Science of Porto AlegreCompleted
-
National Taiwan University HospitalNational Science Council, TaiwanCompleted